Suppr超能文献

[西班牙穆尔西亚地区抗高血压药物合理使用情况分析]

[Analysis of the rational use of anti-hypertensives in the Murcia (Spain) region].

作者信息

Ruiz Juan C, Ariza María A, Aguilera Belén, Leal Mariano, Gómez Ramón, Abellán José

机构信息

Servicio de Farmacia, Área de Salud VIII Mar Menor, Hospital Los Arcos, Santiago de la Ribera, Murcia, España.

出版信息

Aten Primaria. 2012 May;44(5):272-9. doi: 10.1016/j.aprim.2011.04.006. Epub 2012 Jan 31.

Abstract

OBJECTIVE

The objective of this study was to determine the pattern of use of antihypertensive drugs in the Murcia Region, comparing the results with the national data, and detecting problems in order to make improvements, or establish hypotheses and to plan new studies.

DESIGN

Pharmacoepidemiological study (from 2004 to 2008) in accordance with the recommendations from World Heath Organization.

SETTING

: Murcia Region.

PARTICIPANTS

Annual census of each year.

MAIN MEASUREMENTS

The use of antihypertensive drugs was measured by the daily doses per 1000 inhabitans-day (DHD).

RESULTS

The use of antihypertensive drugs has significantly increased from 196.6 DHD to 235.8 DHD. The antihypertensives more used at the end of 2008 were: angiotensin II receptor blockers-ARB- (38.6%) and angiotensin converting enzyme inhibitors-ACEI- (21.8%). There has been a tendency to change the use of rennin-angiotensin system blockers-RASB-, with an increase in ARB of 77.5% and and a decrease in ACEI 9.5%. The comparison with the national data shows qualitative and quantitative differences in the pattern of antihypertensive drugs used during the studied period.

CONCLUSIONS

The use of antihypertensive drugs in Murcia is less than in the rest of Spain. Therefore, this may be due to a problem of under treatment of this illness or other cardiovascular illnesses in the region. A greater use of ARB in Murcia and a lower use of ACEI was observed in Murcia. The differences found suggest that further studies are required to clarify their origins and causes, with the objective of achieving a more rational and efficient use of these drugs.

摘要

目的

本研究旨在确定穆尔西亚地区抗高血压药物的使用模式,将结果与全国数据进行比较,并发现问题以进行改进,或建立假设并规划新的研究。

设计

根据世界卫生组织的建议进行的药物流行病学研究(2004年至2008年)。

地点

穆尔西亚地区。

参与者

每年的年度普查。

主要测量指标

抗高血压药物的使用通过每1000居民日的日剂量(DHD)来衡量。

结果

抗高血压药物的使用已从196.6 DHD显著增加至235.8 DHD。2008年底使用最多的抗高血压药物为:血管紧张素II受体阻滞剂(ARB,38.6%)和血管紧张素转换酶抑制剂(ACEI,21.8%)。肾素-血管紧张素系统阻滞剂(RASB)的使用有变化趋势,ARB增加了77.5%,ACEI减少了9.5%。与全国数据的比较显示,在研究期间抗高血压药物使用模式存在定性和定量差异。

结论

穆尔西亚地区抗高血压药物的使用低于西班牙其他地区。因此,这可能是由于该地区这种疾病或其他心血管疾病治疗不足的问题。在穆尔西亚观察到ARB的使用较多而ACEI的使用较少。发现的差异表明需要进一步研究以阐明其来源和原因,目的是实现这些药物更合理和有效的使用。

相似文献

4
7
[Trends in antibiotic consumption in Spain, 1985-2000].[1985 - 2000年西班牙抗生素消费趋势]
Med Clin (Barc). 2002 Apr 27;118(15):561-8. doi: 10.1016/s0025-7753(02)72453-6.

本文引用的文献

1
[Hypertension and health policy in Spain].[西班牙的高血压与健康政策]
Med Clin (Barc). 2009 Feb 21;132(6):222-9. doi: 10.1016/j.medcli.2008.09.034. Epub 2009 Feb 12.
4
Essential hypertension.原发性高血压
Lancet. 2007 Aug 18;370(9587):591-603. doi: 10.1016/S0140-6736(07)61299-9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验